A new type of treatment for cardiac fibrosis is on the horizon. Fibrosis occurs when an excess amount of matrix proteins, like collagen, develops and leaves pathological scarring. The heart becomes “stiff”. With inflexibility, the heart can not work properly, ie. it can not flex and relax.
Cardiac disease is the leading cause of death in the “Western world”. And with heart disease being so prevalent, too many patients deal with cardiac fibrosis on a daily basis.
The National Institutes of Health and the Novartis Corp. have funded an animal study that may lead to a possible treatment…
The …read more

Thanks to more effective medicines and treatments, death among heart failure patients has halved over the last 6 years. Also, incidence of stroke and heart attack after discharge fell over the first half of this decade.
— The death rate for patients admitted with a severe heart attack, where the arteries are completely blocked, went down from 8.4 to 4.5 per cent.
– The risk of heart failure for severe heart attack patients also went down from 20 to 11 per cent.
– The death rate for patients admitted with a milder heart attack, where the arteries are only partially blocked, …read more